1. The medical laboratory of MyGenostics has successively obtained the CNAS (ISO15189) and CAP quality system certifications, and has passed the NGS-B capability assessment of CAP PT (Proficiency Testing) several times.

2. In 2023, MyGenostics passed 9 inter-room quality assessments of the National Proctors Centre with full scores.

3. In addition, MyGenosticshas has obtained the ISO13485 certification for medical devices, with an annual production of 28.47 million IVD reagents, 29.2 million LDT reagents, and an annual production capacity of up to 104,025 sets of instruments.

Dr. Wu Jian, founder of Mygenostics

Chairman, Professor-level Senior Engineer
Chief Scientist

·Beijing Nova program
·Beijing Overseas High-level Talent
·National Innovation and Entrepreneurship Talent
·Beijing Youth talent 
·National 10,000 Talents Program-Young Talent

Core Technology - GenGap Gene Capture Technology

GenGap technology can capture human genome fragments flexibly and efficiently, combined with the next generation of high-throughput sequencing technology, it can be applied to large-scale gene research and screening.

1. One of the world's top three capture technology platforms, the earliest to realise deletion and duplication analysis through capture sequencing;
2. The earliest to use capture sequencing for genetic testing in China, effectively reducing sequencing costs;
3. The technology has reached the leading level in China,entered the stage of industrialization;
4. A platform for clinical mutation gene screening, diagnosis and personalized drug treatment genetic information was established in China
.

Outstanding scientific research transformation ability


-National Key Research and Development Program of China - 3

-Major Project of the Ministry of Science and Technology - 2

-Special Project of the Ministry of Science and Technology - 1

-SCI Academic Papers - 924

-Patents - 39

-Software Copyright - 80

-Commercialization of Scientific and Research Findings Award - 4